Ozempic

Page 5 of 8

How Eli Lilly went from pharmaceutical slowpoke to $791 billion juggernaut
Magazine

How Eli Lilly went from pharmaceutical slowpoke to $791 billion juggernaut

By
August 2, 2024
Angela Fitch. cofounder and chief medical officer of knownwell.
Commentary

I’m an obesity medicine doctor and I’ve been on weight-loss drugs like Ozempic for a decade. Here’s why I think they aren’t a fad

By
July 30, 2024
Thomas Schinecker, CEO of Roche Holding.
Retail

An obesity pill study tested on just 25 patients led to a stunning $16.8 billion increase in Swiss drugmaker Roche’s market value

By Naomi Kresge, Lisa Pham and Bloomberg
July 23, 2024
Obesity medicine physician Dr. Nisha Patel breaks down five weight loss myths that “need to die” with Coins2Day.
Health

The 5 biggest weight loss myths that ‘need to die,’ according to an obesity doctor

By
July 18, 2024
A bathroom scale is surrounded by colorful pills.
Health

Pharma giant Pfizer is trying to cash in on the weight loss drug craze with a new pill that could be a welcome needle-free alternative to pesky GLP-1 shots

By Damian Garde and Bloomberg
July 11, 2024
A person using Ozempic on November 2, 2023, in Madrid, Spain. Novo Nordisk, the Danish firm that manufactures Ozempic, has reported record quarterly results, up almost 3% on the stock market. The company's revenues rose by 38% to DKK 58.73 billion, some 7.8 billion euros. Ozempic is a diabetic drug that causes a loss of up to 15% of body weight because it acts as an appetite suppressant, a side effect that has made the drug fashionable on social media as a weight loss drug.
Features

Ozempic and Wegovy are marketed as a short-term holy grail for weight loss by some startups. Doctors disagree

By Jessica Mathews and Alena Botros
July 9, 2024
Close-up of an Ozempic pen in a greenwash style
Health

Ozempic linked to rare cases of vision loss in Harvard study

By Robert Langreth and Bloomberg
July 3, 2024
Fake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs
Health

Fake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs

By
June 28, 2024
Lars Fruergaard Jorgensen, CEO of Novo Nordisk.
Health

A rare setback as Ozempic-maker Novo Nordisk takes a $820 million hit as its next wonder drug fails

By Naomi Kresge and Bloomberg
June 27, 2024
EU urges clampdown on cosmetic misuse of Novo’s Ozempic amid worsening drug shortages for diabetics
Health

EU urges clampdown on cosmetic misuse of Novo’s Ozempic amid worsening drug shortages for diabetics

By Naomi Kresge and Bloomberg
June 26, 2024
Danone and Nestle search for a way around Ozempic Revolution with high protein yogurt and vitamins against hair-loss
Health

Danone and Nestle search for a way around Ozempic Revolution with high protein yogurt and vitamins against hair-loss

By Dasha Afanasieva, Deena Shanker and Bloomberg
June 24, 2024
A photo of the packet for anti-obesity drug Wegovy.
Tech

India’s gray market is selling Wegovy at less than 10% of U.S. prices—even though weight-loss drugs aren’t officially available in the country

By Satviki Sanjay and Bloomberg
June 19, 2024
Baggy pants are out and smaller sizes are flying off the shelves as Wegovy changes how Americans buy clothes
Retail

Baggy pants are out and smaller sizes are flying off the shelves as Wegovy changes how Americans buy clothes

By
June 17, 2024
Lars Fruergaard Jorgensen, chief executive officer of Novo Nordisk A/S, gestures while speaking during a Bloomberg Television interview in London, U.K.
Retail

Ozempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled in front of Bernie Sanders to explain why

By
June 17, 2024
CEO Sima Sistani didn’t think running WeightWatchers would be this hard
Newsletters

CEO Sima Sistani didn’t think running WeightWatchers would be this hard

By Emma Hinchliffe and Joey Abrams
June 11, 2024

Most Popular